Duration of Anaesthesia Induction in Paediatric Patients: Prospective Observational Trial
Induration
Duration of Inhalation Versus Intravenous Anaesthesia Induction in Paediatric Patients: Prospective Observational Trial
1 other identifier
observational
1,000
1 country
1
Brief Summary
Intravenous anaesthesia induction is nowadays considered as gold standard, mainly because of the possibility of the rapid therapeutic intervention while having secured i.v. line. In the paediatric patients, apart from intravenous induction, it is also possible to use in the specific situations inhalation anaesthesia induction with sevoflurane (in the mixture with O2 + air, or O2 + N2O) and secure the i.v. line afterwards in the inhalation anaesthesia. This method is in the paediatric population currently preferred, mainly because of possible fear of the painful venipuncture. Inhalation anaesthesia induction is possible only in patients without the risk of aspiration/regurgitation of stomach content and in patients without predicted difficult airway. Even if sedative premedication is used, during the inhalation induction excitation stage of the general anaesthesia variably appears, during which hemodynamic sympathoadrenal response and involuntary limbs movement might occur. When deepening inhalation anaesthesia, progression to surgical stage and automatic breathing onset appears. This subsequently facilitates to secure the venous access, without which is is not possible to secure the airway (in exception of the emergency situations - resuscitation).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2020
CompletedFirst Posted
Study publicly available on registry
August 27, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedMarch 2, 2022
February 1, 2022
1.4 years
August 21, 2020
February 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
duration of anaesthesia induction
The average duration of inhalation and intravenous anaesthesia induction will be measured, defined as the time since the beginning of monitoring of the vital functions (ECG, pulse oximetry, non-invasive blood pressure measurement) until the first ETCO2 wave.
Intraoperatively
Secondary Outcomes (6)
The number of attempts needed to secure i.v. line
Intraoperatively
success rate of securing the i.v. line while using EMLA patch and/or Buzzy
Intraoperatively
Airway management
Intraoperatively
incidence of adverse events
Intraoperatively
Type of premedication
Intraoperatively
- +1 more secondary outcomes
Study Arms (2)
Paediatric patients with inhalation induction
The measurement will begin after the patient's arrival at the operating theatre, after the control of the documentation and beginning of the vital signs monitoring. The measurement will be terminated at the occurence of the first ETCO2 wave, after securing the airway with laryngeal mask or orotracheal intubation. For the inhalation induction sevoflurane will be used (in the mixture with O2 + air, or O2 + N2O).
Paediatric patients with intravenous induction
The measurement will begin after the patient's arrival at the operating theatre, after the control of the documentation and beginning of the vital signs monitoring. The measurement will be terminated at the occurence of the first ETCO2 wave, after securing the airway with laryngeal mask or orotracheal intubation. For the inhalation induction sevoflurane will be used (in the mixture with O2 + air, or O2 + N2O). For the intravenous induction, commonly used induction anaesthetics will be used (propofol, etomidate, ketamine, midazolam).
Interventions
For the inhalation induction sevoflurane will be used (in the mixture with O2 + air, or O2 + N2O).
For the intravenous induction, commonly used induction anaesthetics will be used (propofol, etomidate, ketamine, midazolam).
Eligibility Criteria
Pediatric patients scheduled for elective surgical or diagnostic procedure in the term from 10.9.2020 until 30.6.2021.
You may qualify if:
- paediatric patients scheduled for elective surgical or diagnostic procedure in the term from 10.9.2020 until 30.6.2021.
You may not qualify if:
- Patients in the age from 0 to 1 month
- patients with predicted difficult airway
- emergency/urgent surgeries
- patients at the risk of regurgitation/aspiration of the stomach content
- procedures in which the airway will not be secured with laryngeal mask or orotracheal intubation
- cases were the time of induction can not be measured
- patients with intravenous line in situ
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Brno
Brno, 62500, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Petr Štourač, prof. MD., Ph.D.
Faculty of medicince Masaryk University and University Hospital Brno
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- prof.MD,Ph.D.
Study Record Dates
First Submitted
August 21, 2020
First Posted
August 27, 2020
Study Start
October 1, 2020
Primary Completion
February 28, 2022
Study Completion
February 28, 2022
Last Updated
March 2, 2022
Record last verified: 2022-02